Targeting of αv-integrins in stem/progenitor cells and supportive microenvironment impairs bone metastasis in human prostate cancer

Neoplasia

Volumn 13, Issue 6, 2011, Pages 516-525

  van der Horst, Geertje ^a   van den Hoogen, Christel ^a   Buijs, Jeroen T ^a   Cheung, Henry ^a   Bloys, Henny ^a   Pelger, Rob C M ^a   Lorenzon, Giocondo ^b   Heckmann, Bertrand ^b   Feyen, Jean ^b   Pujuguet, Philippe ^b   Blanque, Roland ^b   Clément Lacroix, Philippe ^b   van der Pluijm, Gabri ^a,b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Galapagos SASU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE DEHYDROGENASE; ANTINEOPLASTIC AGENT; CD51 ANTIGEN; GLPG 0187; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN; ZOLEDRONIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE METASTASIS; CANCER STEM CELL; CARCINOGENESIS; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG INHIBITION; DRUG TARGETING; FETUS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NEWBORN; NONHUMAN; OSTEOCLASTOGENESIS; OSTEOLYSIS; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; TREATMENT OUTCOME; TUMOR GROWTH;

EID: 79958161708     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.11122     Document Type: Article

References (8)

1. Clément-Lacroix P, Berrocal E, Heckmann B, Wigerinck P, Lorenzon G, and Pujuguet P (2011). GLPG0187 inhibits progression of established bone metastasis and achieves maximum efficacy when combined with standard-of-care metastatic breast cancer treatments. Bone 48, S45.
2. 1. Biochem J 350, 485-493.
3. Humphries M (2008). Integrin antagonist specificity profiling. Study report BC#0016/Report GLPG0187-PD-003.
4. 1 integrin-Fc fragment. J Biol Chem 276, 35854-35866.
5. 5 subunit. J Biol Chem 272, 17283-17292.
6. 1 using a gain-of-function approach. Biochem J 424, 179-189.
7. Kapadia RD, Stroup GB, Badger AM, Koller B, Levin JM, Coatney RW, Dodds RA, Liang X, Lark MW, and Gowen M (1998). Applications of micro-CT and MR microscopy to study pre-clinical models of osteoporosis and osteoarthritis. Technol Health Care 6(5-6), 361-372.
8. Rüegsegger P, Koller B, and Müller R (1996). A microtomographic system for the nondestructive evaluation of bone architecture. Calcif Tissue Int 58(1), 24-29.